GENEREX BIOTECHNOLOGY CORPORATION
June 19, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
| RE: | Generex Biotechnology Corporation (the “Company”) |
| (Accession No. 0001607062-20-000159) | |
| Form AW Application for Withdrawal |
Ladies and Gentlemen:
Pursuant to Rule 477 under the Securities Act of 1933, as amended, the Company hereby requests the withdrawal of the Company’s Form S-1/A registration statement (Accession No. 0001607062-20-000159) filed on June 15, 2020 with respect to the Company’s Series A Preferred Stock.
The Form S-1/A was incorrectly tagged as an S-1/A filing instead of a Form S-1 filing. A correctly tagged submission was subsequently filed as a Form S-1 filing. No securities were sold in connection with the offering.
If you have any questions, please call Jeff Wofford of Carmel, Milazzo & Feil LLP at (646) 876-0618.
Very Truly Yours,
GENEREX BIOTECHNOLOGY CORPORATION
By:/s/ Anthony Crisci
Name: Anthony Crisci
Title: Chief Legal Officer & Chief Administrative Officer